Sravani A, Thomas J
Heliyon. 2025; 11(3):e41964.
PMID: 39959483
PMC: 11830326.
DOI: 10.1016/j.heliyon.2025.e41964.
Megid R, Ribeiro G, Gomes I, Laus A, Leal L, Sussuchi da Silva L
Front Mol Biosci. 2025; 12:1537523.
PMID: 39950162
PMC: 11821485.
DOI: 10.3389/fmolb.2025.1537523.
Mukherjee P, Mahanty M, Dutta B, Rahaman S, Sankaran K, Rahaman S
bioRxiv. 2024; .
PMID: 39574752
PMC: 11580895.
DOI: 10.1101/2024.11.05.622116.
Alqithami S, Machwe A, Orren D
Cells. 2024; 13(17.
PMID: 39273025
PMC: 11394110.
DOI: 10.3390/cells13171453.
Cao Y
Cell Biosci. 2024; 14(1):104.
PMID: 39164745
PMC: 11334496.
DOI: 10.1186/s13578-024-01282-w.
NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.
Zhang A, Peng S, Sun S, Ye S, Zhao Y, Wu Q
Cancer Med. 2024; 13(16):e70100.
PMID: 39149873
PMC: 11327863.
DOI: 10.1002/cam4.70100.
IL-1β-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial-mesenchymal transition.
Tabei Y, Nakajima Y
Cell Commun Signal. 2024; 22(1):392.
PMID: 39118068
PMC: 11308217.
DOI: 10.1186/s12964-024-01775-8.
TSP50 facilitates breast cancer stem cell-like properties maintenance and epithelial-mesenchymal transition via PI3K p110α mediated activation of AKT signaling pathway.
Gao F, Liu S, Wang J, Wei G, Yu C, Zheng L
J Exp Clin Cancer Res. 2024; 43(1):201.
PMID: 39030572
PMC: 11264956.
DOI: 10.1186/s13046-024-03118-4.
TFAP2A downregulation mediates tumor-suppressive effect of miR-8072 in triple-negative breast cancer via inhibiting SNAI1 transcription.
Fang Y, Wang Y, Ma H, Guo Y, Xu R, Chen X
Breast Cancer Res. 2024; 26(1):103.
PMID: 38890750
PMC: 11186287.
DOI: 10.1186/s13058-024-01858-x.
MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.
Tolue Ghasaban F, Ghanei M, Mahmoudian R, Taghehchian N, Abbaszadegan M, Moghbeli M
Heliyon. 2024; 10(9):e30599.
PMID: 38726188
PMC: 11079401.
DOI: 10.1016/j.heliyon.2024.e30599.
Integrative methylome and transcriptome analysis reveals epigenetic regulation of in laryngeal cancer.
Yuan X, Lau H, Huang H, Hsueh C, Gong H, Zhou L
Microb Genom. 2024; 10(3).
PMID: 38536233
PMC: 10995630.
DOI: 10.1099/mgen.0.001221.
A dynamic model of inorganic arsenic-induced carcinogenesis reveals an epigenetic mechanism for epithelial-mesenchymal plasticity.
Rea M, Kimmerer G, Mittendorf S, Xiong X, Green M, Chandler D
Environ Pollut. 2024; 347:123586.
PMID: 38467368
PMC: 11005477.
DOI: 10.1016/j.envpol.2024.123586.
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
Bhat G, Sethi I, Sadida H, Rah B, Mir R, Algehainy N
Cancer Metastasis Rev. 2024; 43(1):197-228.
PMID: 38329598
PMC: 11016008.
DOI: 10.1007/s10555-024-10172-z.
K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3.
Geissert R, Lammert A, Wirth S, Honig R, Lohfink D, Unger M
Cell Commun Signal. 2024; 22(1):85.
PMID: 38291468
PMC: 10826106.
DOI: 10.1186/s12964-024-01484-2.
ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
Nie J, Dang S, Zhu R, Lu T, Zhang W
Breast Cancer Res. 2024; 26(1):19.
PMID: 38287441
PMC: 10826190.
DOI: 10.1186/s13058-024-01771-3.
Prostate transmembrane androgen inducible protein 1 : regulation and clinical implications.
Zhu Q, Wang Y, Liu Y, Yang X, Shuai Z
Front Oncol. 2024; 13:1298660.
PMID: 38173834
PMC: 10761476.
DOI: 10.3389/fonc.2023.1298660.
Role of Akt/Protein Kinase B in Cancer Metastasis.
Islam M, Jones S, Ellis I
Biomedicines. 2023; 11(11).
PMID: 38002001
PMC: 10669635.
DOI: 10.3390/biomedicines11113001.
Patterns of Gene Expression Profiles Associated with Colorectal Cancer in Colorectal Mucosa by Using Machine Learning Methods.
Ren J, Chen L, Guo W, Feng K, Cai Y, Huang T
Comb Chem High Throughput Screen. 2023; 27(19):2921-2934.
PMID: 37957897
DOI: 10.2174/0113862073266300231026103844.
Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer.
Zhang Z, Wang X, Kim M, He D, Wang C, Fong K
Prostate. 2023; 83(15):1458-1469.
PMID: 37475584
PMC: 11618820.
DOI: 10.1002/pros.24602.
Lysyl oxidase like-2 in fibrosis and cardiovascular disease.
Poe A, Martinez Yus M, Wang H, Santhanam L
Am J Physiol Cell Physiol. 2023; 325(3):C694-C707.
PMID: 37458436
PMC: 10635644.
DOI: 10.1152/ajpcell.00176.2023.